Cigna (CI – Research Report) received a Buy rating and a $320.00 price target from Bank of America Securities analyst Kevin Fischbeck today. The company’s shares closed yesterday at $262.74. According to TipRanks, Fischbeck is a 4-star analyst with an average return of 2.9% and a 59.01% success rate. Fischbeck covers the Healthcare sector, focusing on stocks such as UnitedHealth, Universal Health, and Surgery Partners. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cigna with a $317.69 average price target, implying a 20.91% upside from current levels. In a report released on May 30, J.P. Morgan also maintained a Buy rating on the stock with a $356.00 price target. See today’s best-performing stocks on TipRanks >> Based on Cigna’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $32.14 billion and a net profit of $1.31 billion. In comparison, last year the company earned a revenue of $32.33 billion and had a net profit of $1.13 billion
		  TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Founded in 1792, Cigna Corporation is a Connecticut-based global health services company, which provides insurance and related products and services. It operates through the following segments: Health Services, Integrated Medical, International Markets, and Group Disability and Other.  Read More on CI: Indices Commodities Currencies Stocks